Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Maximum days for report: 14 days

What are the prerequisites for the test RET Oncogene- 2 Exons Test

  • Sample Type: Blood or tissue sample
  • Specimen: Fresh or frozen tissue or blood in EDTA tube
  • Minimum Volume: 2 mL blood or 20 mg tissue
  • Storage: Samples should be stored at 2-8°C and shipped on ice packs
  • Turnaround Time: 5-7 days

What are the measure values for the test RET Oncogene- 2 Exons Test

  • Exon 1: 0.5 - 2.0
  • Exon 2: 0.2 - 1.5

What does this test RET Oncogene- 2 Exons Test identify?

Test: RET Oncogene - 2 Exons Test

The RET Oncogene - 2 Exons Test is a genetic test that identifies mutations in the RET gene, specifically in 2 specific exons. The RET gene provides instructions for producing a protein that is involved in cell signaling and growth. Mutations in the RET gene can lead to the development of certain types of cancer, particularly thyroid cancer and adrenal gland cancer.

By analyzing the DNA sequence of the two exons in the RET gene, this test can help in identifying individuals who may have an increased risk of developing these types of cancer. This information can be used for early detection, personalized treatment plans, and genetic counseling for at-risk individuals and their families.

Why is this test RET Oncogene- 2 Exons Test taken?

The RET Oncogene - 2 Exons Test is taken to detect mutations in the RET gene. The RET gene provides instructions for making a protein that is involved in the normal development and maturation of nerve cells and the formation of neural crest cells, which are a group of cells that migrate to different parts of the body during embryonic development. Mutations in the RET gene can lead to the development of certain types of cancer, particularly thyroid cancer and multiple endocrine neoplasia type 2 (MEN2).

By analyzing the two specific exons of the RET gene, this test can identify mutations that may increase a person's risk of developing cancer. This information can help healthcare providers determine appropriate screening, monitoring, and treatment strategies for individuals with these mutations.

No FAQs available.

Customer Google Rating